A model predicting mortality of hospitalized Covid-19 patients four days after admission: development, internal and temporal-external validation

S Heber, D Pereyra, WC Schrottmaier… - Frontiers in cellular …, 2022 - frontiersin.org
Objective To develop and validate a prognostic model for in-hospital mortality after four days
based on age, fever at admission and five haematological parameters routinely measured in …

Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19

E Zendedel, L Tayebi, M Nikbakht… - Current Stem Cell …, 2024 - ingentaconnect.com
Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns

E Torki, A Gharezade, M Doroudchi, S Sheikhi… - Clinical and …, 2023 - Springer
The immune system is tightly regulated to prevent immune reactions to self-antigens and to
avoid excessive immune responses during and after challenges from non-self-antigens …

Post‐hospitalization rehabilitation alleviates long‐term immune repertoire alteration in COVID‐19 convalescent patients

B Feng, D Zheng, L Yang, Z Su, L Tang, Y Zhu… - Cell …, 2023 - Wiley Online Library
The global pandemic of Coronavirus disease 2019 (COVID‐19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an once‐in‐a‐lifetime public health …

[HTML][HTML] Иммунологические особенности пациентов с COVID-19 в зависимости от степени тяжести заболевания

ЕВ Фролова, ЛВ Филиппова… - Проблемы …, 2021 - cyberleninka.ru
COVID-19 (Coronavirus disease 2019)–это инфекционное заболевание, вызываемое
новым β-коронавирусом, который называется коронавирус 2 тяжелого острого …

The neutrophil-to-lymphocyte ratio at the time of admission: a new prognostic indicator for hospital mortality of trauma patients

H Fouladseresht, S Bolandparvaz… - Iranian Journal of …, 2021 - ijaai.tums.ac.ir
The elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poor clinical outcomes,
especially in pro-inflammatory states such as surgical injuries and severe hemorrhages …

Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes

M Messing, MS Sekhon, MR Hughes, S Stukas… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic continues to challenge the capacities of hospital ICUs which
currently lack the ability to identify prospectively those patients who may require extended …

sTREM-1 as a Predictive Biomarker for Disease Severity and Prognosis in COVID-19 Patients

N Geng, Z Wu, Z Liu, W Pan, Y Zhu, H Shi… - Journal of …, 2024 - Taylor & Francis
Background Research on biomarkers associated with the severity and adverse prognosis of
COVID-19 can be beneficial for improving patient outcomes. However, there is limited …

Analyzing correlation of clinical severity of COVID-19 with other biochemical parameters: a retrospective study from Pakistan

I Naeem, B Wahid - The Tohoku Journal of Experimental Medicine, 2021 - jstage.jst.go.jp
The third wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
causing damage all over the world, especially in Pakistan and India. Although vaccines are …

Development and external validation of a logistic regression derived formula based on repeated routine hematological measurements predicting survival of …

S Heber, D Pereyra, WC Schrottmaier, K Kammerer… - medRxiv, 2020 - medrxiv.org
Abstract Background The Covid-19 pandemic has become a global public health crisis and
providing optimal patient care while preventing a collapse of the health care system is a …